Consejo Superior De Investigaciones Cientificas

Fundacion Publica Andaluza Progreso Y Salud

Puleva Biotech, S.a.

Juan Carlos Morales Sánchez

Pablo Peñalver Puente

Julio Boza Puerta

Adoración Montero Sánchez

Francisco Javier Díaz Corrales

Eduardo Lopez-Huertas Leon

Maria Luisa Mateos Martin

Arjan Geelings

Efres Belmonte Reche

María Lourdes Valdés Sánchez

Jesús Jimenez Lopez

Elena González Rey

Ana Belén García Delgado

The present invention relates to a group of compounds derived from resveratrol having as substituents at least one silyl group which, in turn, can be substituted by different groups. The invention also relates to the therapeutic use of these compounds in inflammatory, neurological, and neurodegenerative diseases.

Silylated derivatives of resveratrol and the use thereof in neurodegenerative, neurological or inflammatory diseases

The present invention relates to the therapeutic use of acylated piceid derivative compounds in ocular pathologies, in particular retinitis pigmentosa and in age-related macular degeneration.

Acylated compounds for the treatment of ocular pathologies

The present invention refers to the use of phenolic compounds and their derivatives represented by formula I wherein Rand Rare selected from among: OH, OCOalkyl, or OCOalkenyl, and Ris either H, OH, OCOalkyl or OCOalkenyl, wherein the alkyl or alkenyl chains present from 2 to 22 carbon atoms and wherein at least one OCOalkyl or OCOalkenyl group is present in the structure, for the prevention and treatment of cardiovascular, hepatic or renal diseases, as well as to their cosmetic applications, to compositions that include these compounds and to some novel phenolic compounds and derivatives.

Natural compounds and their derivatives for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications

Growing community of inventors

Granada, Spain

Juan Carlos Morales Sánchez